Stocks Hitting 52-Week Lows

 

  • Juno Therapeutics Inc JUNO shares reached a new 52-week low of $20.45 as the company disclosed that it has placed JCAR015 Phase II ROCKET trial on clinical hold after 2 patients suffered cerebral edema earlier this week.
  • BioDelivery Sciences International, Inc. BDSI shares fell 5.9 percent to touch a new 52-week low of $1.60. BioDelivery Sciences shares have dropped 72.13 percent over the past 52 weeks, while the S&P 500 index has increased 5.58 percent in the same period.
  • Eli Lilly and Co LLY shares reached a new 52-week low of $66.61 after the company’s drug solanezumab failed to meet primary endpoint for the treatment of mild dementia due to Alzheimer's disease in a late-stage study.
  • AstraZeneca plc (ADR) AZN shares touched a new 52-week low of $26.075. AstraZeneca shares have dropped 22.17 percent over the past 52 weeks, while the S&P 500 index has gained 5.58 percent in the same period.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarkets52 Week Lows52-Week Lows
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!